BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30830556)

  • 1. In response to the FDA warning about the use of photomedicine in gynecology.
    Escribano JJ; González-Isaza P; Tserotas K; Athanasiou S; Zerbinati N; Leibaschoff G; Salvatore S; Sánchez-Borrego R
    Lasers Med Sci; 2019 Sep; 34(7):1509-1511. PubMed ID: 30830556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lasers and energy-based devices marketed for vaginal rejuvenation: A cross-sectional analysis of the MAUDE database.
    Ahluwalia J; Avram MM; Ortiz AE
    Lasers Surg Med; 2019 Oct; 51(8):671-677. PubMed ID: 30924953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lasers in gynaecology.
    Phillips C; Hillard T; Salvatore S; Toozs-Hobson P; Cardozo L
    Eur J Obstet Gynecol Reprod Biol; 2020 Aug; 251():146-155. PubMed ID: 32505055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaginal energy-based devices: characterization of adverse events based on the last decade of MAUDE safety reports.
    Wallace SL; Sokol ER; Enemchukwu EA
    Menopause; 2020 Sep; 28(2):135-141. PubMed ID: 33003133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laser-Based Devices for Female Genitourinary Indications: Position Statements From the European Society for Sexual Medicine (ESSM).
    Romero-Otero J; Lauterbach R; Aversa A; Serefoglu EC; García-Gómez B; Parnham A; Skrodzka M; Krychman M; Reisman Y; Corona G; Lowenstein L
    J Sex Med; 2020 May; 17(5):841-848. PubMed ID: 32201147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiofrequency-Based Devices for Female Genito-Urinary Indications: Position Statements From the European Society of Sexual Medicine.
    Romero-Otero J; Lauterbach R; Aversa A; Serefoglu EC; García-Gómez B; Parnhan A; Skrodzka M; Krychman M; Reisman Y; Corona G; Lowenstein L
    J Sex Med; 2020 Mar; 17(3):393-399. PubMed ID: 32129169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The energy based devices for vaginal "rejuvenation," urinary incontinence, vaginal cosmetic procedures, and other vulvo-vaginal disorders: An international multidisciplinary expert panel opinion.
    Digesu GA; Tailor V; Preti M; Vieira-Baptista P; Tarcan T; Stockdale C; Mourad S
    Neurourol Urodyn; 2019 Mar; 38(3):1005-1008. PubMed ID: 30697814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IUGA committee opinion: laser-based vaginal devices for treatment of stress urinary incontinence, genitourinary syndrome of menopause, and vaginal laxity.
    Shobeiri SA; Kerkhof MH; Minassian VA; Bazi T;
    Int Urogynecol J; 2019 Mar; 30(3):371-376. PubMed ID: 30523374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonsurgical Vulvovaginal Rejuvenation With Radiofrequency and Laser Devices: A Literature Review and Comprehensive Update for Aesthetic Surgeons.
    Qureshi AA; Tenenbaum MM; Myckatyn TM
    Aesthet Surg J; 2018 Feb; 38(3):302-311. PubMed ID: 29040373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonsurgical nonablative treatment of aging skin: radiofrequency technologies between aggressive marketing and evidence-based efficacy.
    Atiyeh BS; Dibo SA
    Aesthetic Plast Surg; 2009 May; 33(3):283-94. PubMed ID: 19437070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive vaginal rejuvenation.
    Hashim PW; Nia JK; Zade J; Farberg AS; Goldenberg G
    Cutis; 2018 Oct; 102(4):243-246. PubMed ID: 30489560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiofrequency in cosmetic dermatology: a review.
    Lolis MS; Goldberg DJ
    Dermatol Surg; 2012 Nov; 38(11):1765-76. PubMed ID: 22913399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonablative cutaneous remodeling using radiofrequency devices.
    Alster TS; Lupton JR
    Clin Dermatol; 2007; 25(5):487-91. PubMed ID: 17870527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review and clinical experience exploring evidence, clinical efficacy, and safety regarding nonsurgical treatment of feminine rejuvenation.
    Gold M; Andriessen A; Bader A; Alinsod R; French ES; Guerette N; Kolodchenko Y; Krychman M; Murrmann S; Samuels J
    J Cosmet Dermatol; 2018 Jun; 17(3):289-297. PubMed ID: 29524292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practice patterns and postoperative complications before and after US Food and Drug Administration safety communication on power morcellation.
    Harris JA; Swenson CW; Uppal S; Kamdar N; Mahnert N; As-Sanie S; Morgan DM
    Am J Obstet Gynecol; 2016 Jan; 214(1):98.e1-98.e13. PubMed ID: 26314519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginal Energy-Based Devices.
    Alshiek J; Garcia B; Minassian V; Iglesia CB; Clark A; Sokol ER; Murphy M; Malik SA; Tran A; Shobeiri SA
    Female Pelvic Med Reconstr Surg; 2020 May; 26(5):287-298. PubMed ID: 32324684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unapproved prescription cough, cold, and allergy drug products: recent US Food and Drug Administration regulatory action on unapproved cough, cold, and allergy medications.
    Ostroff C; Lee CE; McMeekin J
    Chest; 2011 Aug; 140(2):295-300. PubMed ID: 21813527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practice Patterns and Complications of Benign Hysterectomy Following the FDA Statement Warning Against the Use of Power Morcellation.
    Multinu F; Casarin J; Hanson KT; Angioni S; Mariani A; Habermann EB; Laughlin-Tommaso SK
    JAMA Surg; 2018 Jun; 153(6):e180141. PubMed ID: 29641835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rejuvenation of the eye: combined techniques].
    Poignonec S
    Rev Laryngol Otol Rhinol (Bord); 2010; 131(2):167-74. PubMed ID: 21284235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive Vaginal Rejuvenation: Radiofrequency Devices.
    Hoss E; Kollipara R; Fabi S
    Skinmed; 2019; 17(6):396-398. PubMed ID: 31904331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.